PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EV/CE(x) | 1.69 | 1.09 | 0.46 | 0.33 |
What is the latest EV/CE ratio of PIRAMAL PHARMA ?
Year | EV/CE |
---|---|
Mar2024 | 1.69 |
Mar2023 | 1.09 |
Mar2022 | 0.46 |
Mar2021 | 0.33 |
How is EV/CE of PIRAMAL PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 1.69 | 55.05 | |
Mar2023 | 1.09 | 136.96 | |
Mar2022 | 0.46 | 39.39 | |
Mar2021 | 0.33 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹26,586.9 Cr | 2.9% | -12.7% | 57.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,569.0 Cr | 2.8% | -7.5% | 2.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹146,318.0 Cr | -0.2% | -9.9% | 60.4% | Stock Analytics | |
CIPLA | ₹118,110.0 Cr | 4.4% | -0.6% | -1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,926.0 Cr | 4.8% | -2.9% | 15.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,471.5 Cr | NA | -9.4% | -10.2% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 2.9% |
-12.7% |
57.8% |
SENSEX | 1.4% |
-5.3% |
0.3% |
You may also like the below Video Courses